Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis
Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
COVID-19 superinfection by Aspergillus (COVID-19-associated aspergillosis, CAPA) is increasingly observed due to increased awareness and use of corticosteroids. The aim of this study is to compare clinical and imaging features between COVID-19 patients with and without associated pulmonary aspergillosis.
In this case-control study, hospitalized...
Alternative Titles
Full title
Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a919d62959c849dfa9502aedab70e084
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a919d62959c849dfa9502aedab70e084
Other Identifiers
ISSN
2075-4418
E-ISSN
2075-4418
DOI
10.3390/diagnostics12051201